Abstract
B cells play a central role in humoral immunity but also have antibody-independent functions. Studies to date have focused on B cells in blood and secondary lymphoid organs but whether B cells reside in non-lymphoid organs (NLO) in homeostasis is unknown. Here we identify, using intravenous labeling and parabiosis, a bona-fide tissue-resident B cell population in lung, liver, kidney and urinary bladder, a substantial proportion of which are B-1a cells. Tissue-resident B cells are present in neonatal tissues and also in germ-free mice NLOs, albeit in lower numbers than in specific pathogen-free mice and following co-housing with ‘pet-store’ mice. They spatially co-localise with macrophages and regulate their polarization and function, promoting an anti-inflammatory phenotype, in-part via interleukin-10 production, with effects on bacterial clearance during urinary tract infection. Thus, our data reveal a critical role for tissue-resident B cells in determining the homeostatic ‘inflammatory set-point’ of myeloid cells, with important consequences for tissue immunity.
| Original language | English |
|---|---|
| Article number | 7081 |
| Journal | Nature Communications |
| Volume | 14 |
| Issue number | 1 |
| ISSN | 1751-8628 |
| DOIs | |
| Publication status | Published - 12.2023 |
Funding
The Clatworthy Lab is based in the University of Cambridge Molecular Immunity Unit in the MRC Laboratory of Molecular Biology and is grateful for the use of the core facilities. O.S. was supported by the Wellcome PhD\u00A0Clinical Training Fellowship 205250/Z/16/Z and National Institute of Health Research (NIHR) clinical lectureship. S.C. and K.H. were supported by Wellcome Trust Research grant 206194. J.R.F. and M.R.C. were funded by the NIHR Cambridge Biomedical Research Centre and the NIHR Blood and Transplant Research Unit. M.R.C. was also supported by a Medical Research Council New Investigator Research Grant MR/N024907/1, Chan-Zuckerberg Initiative Human Cell Atlas Technology Development Grant, Versus Arthritis Cure Challenge Research Grant (21777) and NIHR Research Professorship RP-2017-08-ST2-002. We thank Drs Carl Anderson and Velislava Petrova (Wellcome Sanger Institute, UK) for support and useful discussions around BCR analysis. This work was performed, in part, using resources provided by the Cambridge Service for Data Driven Discovery (CSD3) operated by the University of Cambridge Research Computing Service (www.csd3.cam.ac.uk), provided by Dell EMC and Intel using Tier-2 funding from the Engineering and Physical Sciences Research Council (capital grant EP/P020259/1), and DiRAC funding from the Science and Technology Facilities Council (www.dirac.ac.uk). The Clatworthy Lab is based in the University of Cambridge Molecular Immunity Unit in the MRC Laboratory of Molecular Biology and is grateful for the use of the core facilities. O.S. was supported by the Wellcome PhD Clinical Training Fellowship 205250/Z/16/Z and National Institute of Health Research (NIHR) clinical lectureship. S.C. and K.H. were supported by Wellcome Trust Research grant 206194. J.R.F. and M.R.C. were funded by the NIHR Cambridge Biomedical Research Centre and the NIHR Blood and Transplant Research Unit. M.R.C. was also supported by a Medical Research Council New Investigator Research Grant MR/N024907/1, Chan-Zuckerberg Initiative Human Cell Atlas Technology Development Grant, Versus Arthritis Cure Challenge Research Grant (21777) and NIHR Research Professorship RP-2017-08-ST2-002. We thank Drs Carl Anderson and Velislava Petrova (Wellcome Sanger Institute, UK) for support and useful discussions around BCR analysis. This work was performed, in part, using resources provided by the Cambridge Service for Data Driven Discovery (CSD3) operated by the University of Cambridge Research Computing Service ( www.csd3.cam.ac.uk ), provided by Dell EMC and Intel using Tier-2 funding from the Engineering and Physical Sciences Research Council (capital grant EP/P020259/1), and DiRAC funding from the Science and Technology Facilities Council ( www.dirac.ac.uk ).
| Funders | Funder number |
|---|---|
| Drs Carl Anderson and Velislava Petrova | |
| Science and Technology Facilities Council | |
| National Institute for Health and Care Research | |
| Wellcome Sanger Institute | |
| NIHR Cambridge Biomedical Research Centre | |
| University of Cambridge Molecular Immunity Unit | |
| UK Research and Innovation | |
| Wellcome Trust Centre for Mitochondrial Research | 206194 |
| Wellcome Trust | 205250/Z/16/Z |
| Medical Research Council | MR/N024907/1 |
| Engineering and Physical Sciences Research Council | EP/P020259/1 |
| Versus Arthritis Cure Challenge Research | RP-2017-08-ST2-002, 21777 |